Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR)

Geode Capital Management LLC decreased its holdings in electroCore, Inc. (NASDAQ:ECOR) by 3.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 61,044 shares of the company’s stock after selling 2,441 shares during the quarter. Geode Capital Management LLC owned 0.92% of electroCore worth $990,000 at the end of the most recent quarter.

Separately, DnB Asset Management AS purchased a new position in shares of electroCore during the fourth quarter valued at approximately $180,000. Institutional investors own 26.74% of the company’s stock.

Insider Buying and Selling at electroCore

In related news, Director Thomas J. Errico acquired 6,000 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were purchased at an average price of $8.10 per share, with a total value of $48,600.00. Following the completion of the purchase, the director now directly owns 256,401 shares of the company’s stock, valued at $2,076,848.10. This represents a 2.40 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

ECOR has been the topic of several research reports. HC Wainwright reaffirmed a “buy” rating and issued a $25.00 target price on shares of electroCore in a research report on Thursday, March 13th. LADENBURG THALM/SH SH dropped their price target on electroCore from $28.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, March 13th.

electroCore Stock Up 2.9 %

Shares of NASDAQ:ECOR opened at $7.57 on Friday. The stock has a market capitalization of $54.45 million, a PE ratio of -4.14 and a beta of 0.83. The firm’s 50 day moving average price is $8.65 and its 200-day moving average price is $12.23. electroCore, Inc. has a twelve month low of $5.02 and a twelve month high of $19.49.

electroCore Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.